Novo CEO pressed by Senate to chop rates of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers with regards to the list costs of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. Will not https://label-the-figure-with-the30516.yomoblog.com/37000858/facts-about-healthcare-news-revealed